Regeneron Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Schenectady, NY and active since 2010.
Regeneron Pharmaceuticals was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Shawn Lemerise at the company’s single location by writing to 2 Fairway Lane, Schenectady, New York NY 12304 or by phoning (518) 488-6135. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Regeneron Pharmaceuticals |
| Contact Person: | Shawn Lemerise |
| Address: | 2 Fairway Lane, Schenectady, New York 12304 |
| Phone Number: | (518) 488-6135 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Regeneron Pharmaceuticals was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Shawn Lemerise for inquiries that concern Regeneron Pharmaceuticals by calling the company number (518) 488-6135, as your correspondence is most welcome. Additionally, the physical location of the single location of Regeneron Pharmaceuticals can be found at the coordinates 42.763752,-73.863788 as well as the street address 2 Fairway Lane in Schenectady, New York 12304.
For its online presence, you may visit Regeneron Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.